Conversely, inflammatory proteins, such as complement C3, complement C9, complement factor B, and complement 4B, were significantly elevated in TNBC patients, suggesting a shift toward a pro-inflammatory HDL-C phenotype in aggressive breast cancer. The gene discussed is C9; the disease is breast carcinoma.